Rigel PharmaceuticalsRIGL
那斯達克 · USD
21.91
+0.85
(+4.04%)
收盤 08/02 03:54 (UTC+8)
盤後
0
0
(0%)
08/02 03:54 (UTC+8)
Rigel PharmaceuticalsRIGL
21.91
+0.85
(+4.04%)
財務數據
損益表
- 0.51
- 0.26
- 0.27
- 0.28
- 0.36
- 0.30
- 0.37
- 0.55
- 0.58
- 0.53
- 128.82
- -49.16
- 3.13
- 4.64
- 27.22
- -17.48
- 24.74
- 50.12
- 4.14
- -7.40
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 53,333 | 57,596 | 55,307 | 36,841 | 29,534 | 35,792 | 28,134 | 26,886 | 26,070 | 51,278 |
營業成本 | 4,409 | 5,789 | 8,026 | 2,807 | 2,025 | 3,790 | 1,268 | 1,075 | 977 | 342 |
營業毛利 | 48,924 | 51,807 | 47,281 | 34,034 | 27,509 | 32,002 | 26,866 | 25,811 | 25,093 | 50,936 |
營業費用 | 36,151 | 35,152 | 33,225 | 33,587 | - | 30,036 | 31,331 | 31,078 | 37,818 | 48,857 |
研發費用 | 8,436 | 5,632 | 6,182 | 5,540 | 6,026 | 3,186 | 6,475 | 4,772 | 10,089 | 15,365 |
推銷及管理費用 | 27,715 | 29,520 | 27,043 | 28,047 | 28,449 | 26,850 | 24,856 | 26,306 | 27,729 | 32,172 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 1,320 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 12,773 | 16,655 | 14,056 | 447 | -6,966 | 1,966 | -4,465 | -5,267 | -12,725 | 2,079 |
其他收入及費用 | 591 | 522 | 425 | 552 | 593 | 678 | 672 | 529 | 393 | 429 |
利息費用 | 1,853 | 1,955 | 2,060 | 2,029 | 1,874 | 1,907 | 1,899 | 1,862 | 1,204 | 1,107 |
稅前純益 | 11,511 | 15,222 | 12,421 | -1,030 | -8,247 | 737 | -5,692 | -6,600 | -13,536 | 1,401 |
所得稅 | 65 | 881 | - | - | - | - | - | - | - | - |
稅後純益 | 11,446 | 14,341 | 12,421 | -1,030 | -8,247 | 737 | -5,692 | -6,600 | -13,536 | 1,401 |
基本每股稅後盈餘(元) | 0.64 | 0.81 | 0.71 | -0.06 | -0.05 | - | -0.03 | -0.04 | -0.08 | 0.00 |
稀釋每股稅後盈餘(元) | 0.63 | 0.81 | 0.71 | -0.06 | -0.05 | 0.01 | -0.03 | -0.04 | -0.08 | 0.01 |
基本平均股數(千股) | 17808.00 | 17647.00 | 17600.00 | 17549.00 | 175200.00 | - | 174360.00 | 173560.00 | 173568.00 | 1728510.00 |
稀釋平均股數(千股) | 18169.00 | 17986.00 | 17648.00 | 17549.00 | 175200.00 | - | 174360.00 | 173560.00 | 173568.00 | 1728560.00 |
還原基本每股稅後盈餘(元) | 0.64 | 0.81 | 0.71 | -0.06 | -0.47 | - | -0.33 | -0.38 | -0.80 | 0.01 |
還原稀釋每股稅後盈餘(元) | 0.63 | 0.81 | 0.71 | -0.06 | -0.47 | 0.05 | -0.33 | -0.36 | -0.80 | 0.06 |
還原基本平均股數(千股) | 17,808 | 17,647 | 17,600 | 17,549 | 17,520 | - | 17,436 | 17,356 | 17,356 | 172,851 |
還原稀釋平均股數(千股) | 18,169 | 17,986 | 17,648 | 17,549 | 17,520 | - | 17,436 | 17,356 | 17,356 | 172,856 |
EBITDA(千元) | 13,778 | 17,505 | 15,023 | 1,453 | -6,178 | 2,677 | -3,606 | -4,488 | -12,043 | 2,613 |